Dublin 2023 conference information pack released
Information pack available here, or see the ENTIS annual conference page for more details.
» Read moreCategory: ENTIS News
Comment on the latest meta-analysis investigating childhood neurodevelopment outcomes following acetaminophen (paracetamol) use in pregnancy
Professor Per Damkier (University of Southern Denmark), Chair of the ENTIS Scientific committee, has provided a comment on the most recent meta-analysis investigating in utero exposure to acetaminophen and childhood neurodevelopment (Ricci et al., 2023). In this comment, published in Paediatric and Perinatal Epidemiology, Prof Damkier highlights important key methodological limitations and notable conflicting findings in the primary source literature. […]
» Read morePregnancy and birth related experiences of postpartum women during the third wave of the COVID-19 pandemic
Researchers affiliated to the ENTIS network, led by Professor Hedvig Nordeng (University of Oslo) and Dr Michael Ceulemans (KU Leuven and Teratology Information Service Lareb), have published the results of a pan-European online questionnaire investigating pregnancy and birth related experiences of women during the third wave of the COVID-19 pandemic. More information can be found here. Photo by Alexander Grey […]
» Read more34th Annual ENTIS Conference: Dublin, September 2023 – Call for abstracts
Prospective delegates are invited to submit research abstracts for the 34th annual ENTIS conference, which will be held in Dublin, Ireland from 31st August – 2nd September 2023. Please see here for the abstract submission template and instructions for authors. More information about the meeting is available here.
» Read more34th Annual ENTIS Conference to be held in Dublin, Ireland
The ENTIS Board, Scientific Committee and Conference Organising Committee are pleased to announce that the 34th Annual ENTIS Conference will be held at the Royal College of Surgeons in Dublin, Ireland. More details will be released on the website shortly. Photo by Thomas Vogel on Unsplash
» Read morePresentations from the 33rd Annual Conference now available in the members area
Presentations from the 33rd Annual Conference are now available in the members area. Abstracts from the conference are available here.
» Read moreClose of the 33rd annual ENTIS conference
Between the 8th and 10th September 2022, Dr Georgios Eleftheriou and colleagues from Poison Control Center and Teratology Information Service at the Papa Giovanni XXIII Hospital hosted the 33rd ENTIS conference in Bergamo, Italy. Engaging key note lectures were provided from internationally renown experts on a range of topics including the teratogenic risks of caffeine, risk communication and scientific misinformation, […]
» Read moreAcetaminophen (paracetamol) in pregnancy, urogenital malformations, and childhood neurodevelopment
Chair of the ENTIS Scientific Committee, Prof Per Damkier, and the Head of UKTIS, Dr Ken Hodson, have published an opinion piece in the Obstetric Medicine journal challenging the findings of a 2021 consensus statement published in Nature Reviews Endocrinology. More information can be found here. Photo by James Yarema on Unsplash
» Read morePosition statement: Live vaccine use following in utero or lactation infliximab exposure
In March 2022 the European Medicines Agency’s (EMA) published a direct healthcare professional communication (DHPC) regarding the use of live vaccines in infants exposed to infliximab in utero or during breastfeeding. The DHPC stated that live vaccines (e.g. BCG vaccine) should not be given to infants less than 12 months after birth following in utero infliximab exposure, and that administration […]
» Read moreCase report of bosentan and sildenafil use in lactation and medication disposition in breastmilk.
ENTIS affiliated researchers from the Department of Pharmaceutical and Pharmacological Sciences, KU Leuven have published a case report of bosentan and sildenafil use in lactation. This report, from the IMI ConcePTION project, presents the clinical and pharmacokinetic data of a single mother-infant pair exposed to bosentan and sildenafil for the treatment of pulmonary arterial hypertension (PAH) during lactation. More information […]
» Read more